HomeAVTE • NASDAQ
add
Aerovate Therapeutics Inc
Previous close
$2.59
Day range
$2.55 - $2.67
Year range
$1.25 - $32.42
Market cap
74.06M USD
Avg Volume
218.86K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 17.41M | -18.52% |
Net income | -16.24M | 17.00% |
Net profit margin | — | — |
Earnings per share | -0.56 | 21.13% |
EBITDA | -17.19M | 19.45% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 88.73M | -34.37% |
Total assets | 90.96M | -35.43% |
Total liabilities | 10.47M | -30.93% |
Total equity | 80.49M | — |
Shares outstanding | 28.87M | — |
Price to book | 0.93 | — |
Return on assets | -42.95% | — |
Return on capital | -49.43% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -16.24M | 17.00% |
Cash from operations | -16.04M | -2.77% |
Cash from investing | 16.07M | 222.37% |
Cash from financing | 22.00K | 10.00% |
Net change in cash | 46.00K | 100.16% |
Free cash flow | -10.67M | -21.40% |
About
Founded
2018
Headquarters
Website
Employees
51
